Public-domain · open source
OpenJurist
← 479 F.2d 257 - In re Kauffman Mutual Fund Actions

In re Kauffman Mutual Fund Actions’s Empirical Analysis

479 F.2d 257 · 1973

Citation profile

163
cited by 163 later decisions
1
cited 1 times by the Supreme Court
17
states following
June 2020
most recently cited

39 federal appellate · 27 district · 32 state decisions

How this case has been cited

Cited by 163 later decisions (1 by the Supreme Court) — most recently June 2020 · most notably In re Kauffman Mutual Fund Actions (1973), Aronson v. Lewis (1984)

39 federal appellate · 27 district · 32 state decisions — followed in 17 states

670197319801990200020102020decided

Later decisions citing this case, by decade. The current decade is in progress, and our corpus holds fewer opinions from the most recent years, so the latest bars are undercounted — not a real decline.

Relationships

Applies 15 U.S.C. § 78J (§ 10 of the Securities Exchange Act of 1934) · 15 U.S.C. § 80A · 28 U.S.C. § 1407

Relies on Conley v. Gibson · Stoll v. Gottlieb · Douglas v. Alabama · Smith v. Sperling · Hawes v. Oakland

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 163 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

  1. ““For lawyers and judges accustomed to the liberalized ‘notice’ pleading of the Federal Rules, F.R.Civ.P. 8, a brief review of the background of Rule 23.1 is in order. Rule 23.1 is not an ordinary, but an exceptional rule of pleading, serving a special purpose, and requiring a different judicial approach. Socially desirable as minority stockholders’ actions may be thought to be, see Emerson and Latch-man, Shareholder Democracy ch. VIII (1954); Pomerantz v. Clark, D.Mass., 1951, 101 F.Supp. 341, 346 , it is normally the directors, not the stockholders, who conduct, the affairs of the company. Hence, to be allowed, sua sponte, to place himself in charge without first affording the directors the opportunity to occupy their normal status, a stockholder must show that his case is exceptional. His initial burden is to demonstrate why the directors are incapable of doing their duty, or as the Court has put it, to show that ‘the antagonism between the directory and the corporate interest . be unmistakable.’ Delaware & Hudson Co. v. Albany & Susquehanna R. R., 1909, 213 U.S. 435, 447 , 29 S.Ct. 540, 543 , 53 L.Ed. 862 . This has long meant, as the Court stated in Hawes v. Oakland, 1881, 104 U.S. 450 , 26 L.Ed. 827 , cited in Delaware, that the ‘cause of failure [to induce corporate action] . . . should be stated with particularity.’ 104 U.S. at 461 , 26 L.Ed. 827 . See also Wathen v. Jackson Oil & Refining Co., 1915, 235 U.S. 635, 639-640 , 35 S.Ct. 225 , 59 L.Ed. 395 . Rule 23.1 — The”
    5 later decisions quote this exact passage
  2. “"Rule 23.1 is not an ordinary, but an exceptional rule of pleading, serving a special purpose, and requiring a different judicial approach [than liberalized notice pleading sanctioned by F. R.Civ.P. 8]. * * * [I]t is clear that the `particularity' must appear in the pleading itself; the stockholder may not plead in general terms, hoping that, by discovery or otherwise, he can later establish a case." 479 F.2d at 263 .”
    5 later decisions quote this exact passage
  3. “I find it hard to imagine that a director, however, unaffiliated, who had participated, or under these circumstances knowingly acquiesced, in a major transaction, albeit for a corporate purpose, would authorize a suit, effectively against himself, claiming that the transaction violated the federal antitrust laws. Even independent watchdogs cannot be thought ready to sign a confession of that magnitude.”
    4 later decisions quote this exact passage

How this case has been treated — in progress

Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.